These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 35598686)

  • 21. Optimisation of 16S rRNA gut microbiota profiling of extremely low birth weight infants.
    Alcon-Giner C; Caim S; Mitra S; Ketskemety J; Wegmann U; Wain J; Belteki G; Clarke P; Hall LJ
    BMC Genomics; 2017 Nov; 18(1):841. PubMed ID: 29096601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 23. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease.
    Sookoian S; Salatino A; Castaño GO; Landa MS; Fijalkowky C; Garaycoechea M; Pirola CJ
    Gut; 2020 Aug; 69(8):1483-1491. PubMed ID: 31900291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients.
    Ge H; Wei W; Tang L; Tian Y; Zhu Y; Luo Y; Liu S
    Medicine (Baltimore); 2022 Jun; 101(25):e29347. PubMed ID: 35758365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive tools.
    Lang S; Farowski F; Martin A; Wisplinghoff H; Vehreschild MJGT; Krawczyk M; Nowag A; Kretzschmar A; Scholz C; Kasper P; Roderburg C; Lammert F; Goeser T; Steffen HM; Demir M
    Sci Rep; 2020 Jun; 10(1):9385. PubMed ID: 32523101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-Related Differences in the Luminal and Mucosa-Associated Gut Microbiome of Broiler Chickens and Shifts Associated with
    Awad WA; Mann E; Dzieciol M; Hess C; Schmitz-Esser S; Wagner M; Hess M
    Front Cell Infect Microbiol; 2016; 6():154. PubMed ID: 27921008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helminth infections and gut microbiota - a feline perspective.
    Duarte AM; Jenkins TP; Latrofa MS; Giannelli A; Papadopoulos E; de Carvalho LM; Nolan MJ; Otranto D; Cantacessi C
    Parasit Vectors; 2016 Dec; 9(1):625. PubMed ID: 27912797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal microbiome dysbiosis associated with duodenum bulb inflammation.
    Fan HN; Zhu P; Zhang J; Zhu JS
    Microb Pathog; 2021 Jan; 150():104711. PubMed ID: 33385493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.
    Ringel Y; Maharshak N; Ringel-Kulka T; Wolber EA; Sartor RB; Carroll IM
    Gut Microbes; 2015; 6(3):173-81. PubMed ID: 25915459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus.
    Ebrahimzadeh Leylabadlo H; Samadi Kafil H; Farajnia S; Shanehbandi D; Yaghoub Moaddab S; Feizabadi MM; Ghotaslou R
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e548-e554. PubMed ID: 33795579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia.
    Liu C; Cheng L; Ji L; Li F; Zhan Y; Wu B; Ke Y; Chen P; Hua F; Yuan L; Min Z; Sun L; Chen H; Cheng Y
    Thromb Res; 2020 Jun; 190():11-19. PubMed ID: 32272276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
    Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altitude-adaption of gut microbiota in Tibetan chicken.
    Du X; Li F; Kong F; Cui Z; Li D; Wang Y; Zhu Q; Shu G; Tian Y; Zhang Y; Zhao X
    Poult Sci; 2022 Sep; 101(9):101998. PubMed ID: 35841636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.
    Zeng F; Su X; Liang X; Liao M; Zhong H; Xu J; Gou W; Zhang X; Shen L; Zheng JS; Chen YM
    BMC Med; 2024 Mar; 22(1):104. PubMed ID: 38454425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index.
    Chuaypen N; Asumpinawong A; Sawangsri P; Khamjerm J; Iadsee N; Jinato T; Sutheeworapong S; Udomsawaengsup S; Tangkijvanich P
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.